↓ Skip to main content

Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

Overview of attention for article published in Applied Health Economics and Health Policy, August 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 X users
facebook
1 Facebook page

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
72 Mendeley
Title
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Published in
Applied Health Economics and Health Policy, August 2019
DOI 10.1007/s40258-019-00500-8
Pubmed ID
Authors

Renée Else Michels, Maria de Fransesco, Koshu Mahajan, Gerald J. D. Hengstman, Krijn M. H. Schiffers, Sangeeta Budhia, Gerard Harty, Marieke Krol

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 15%
Student > Master 8 11%
Student > Ph. D. Student 7 10%
Other 7 10%
Researcher 3 4%
Other 9 13%
Unknown 27 38%
Readers by discipline Count As %
Medicine and Dentistry 19 26%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Neuroscience 4 6%
Economics, Econometrics and Finance 3 4%
Biochemistry, Genetics and Molecular Biology 3 4%
Other 11 15%
Unknown 27 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2020.
All research outputs
#8,577,479
of 26,017,215 outputs
Outputs from Applied Health Economics and Health Policy
#410
of 850 outputs
Outputs of similar age
#139,235
of 354,658 outputs
Outputs of similar age from Applied Health Economics and Health Policy
#16
of 28 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 850 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,658 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.